glp-1 summit Home 2nd GLP-1-Based Therapeutics Summit 2025
Description
Results from a study examining the safety of using liraglutide in patients with moderate to severe renal impairment demonstrated no deleterious effects on serum creatinine (SCr) or increased incidence or severity of adverse events
( 10.1038/s41467-020-14309-w) [DOI] [PMC free article] [PubMed] [Google Scholar] Baggio LL & Drucker DJ
3A and H), markers of an antioxidative response, exhibited a pattern opposite to that of oxidative stress markers among the groups
In this review I aim to re-examine the contested concept of food addiction as a disease in the context of emerging GLP-1based obesity pharmacotherapies, integrating perspectives from neurobiology, societal impacts, and early evidence for their potential application in other substance-use disorders
The area above the belly button often provides suitable subcutaneous tissue for injection, particularly in the upper quadrants of the abdomen
[55] Joseph A
